Suppr超能文献

[慢性阻塞性肺疾病的分期与预后]

[Stage and prognosis of COPD].

作者信息

Akashiba Tsuneto

机构信息

First Department of Internal Medicine, Nihon University School of Medicine.

出版信息

Nihon Rinsho. 2003 Dec;61(12):2089-93.

Abstract

Clinical stages of chronic obstructive pulmonary disease(COPD) have been described in the guideline by American Thoracic Society(ATS), European Respiratory Society(ERS), and Japanese Respiratory Society. Recently, the clinical stage in GOLD(Global Initiative Obstructive Lung Disease) was also published in the guideline as an international standard. Although severity or clinical stages of COPD in ATS, ERS, and JRS guidelines is determined by only % predicted FEV1.0/FVC(%FEV1.0), GOLD guideline added clinical symptoms to %FEV1.0 for determining clinical stages of COPD. Prognosis is also correlated with %FEV1.0 in COPD patients. Prognosis of COPD patients shows a clear decline in proportion to that of %FEV1.0. However, pulmonary circulation disorder also affects the prognosis of COPD. Pulmonary hypertension is often found in severe COPD.

摘要

美国胸科学会(ATS)、欧洲呼吸学会(ERS)和日本呼吸学会在指南中描述了慢性阻塞性肺疾病(COPD)的临床分期。最近,慢性阻塞性肺疾病全球倡议组织(GOLD)的临床分期也作为国际标准在指南中发布。尽管ATS、ERS和日本呼吸学会指南中COPD的严重程度或临床分期仅由预测的FEV1.0/FVC(%FEV1.0)决定,但GOLD指南在%FEV1.0基础上增加了临床症状来确定COPD的临床分期。COPD患者的预后也与%FEV1.0相关。COPD患者的预后与%FEV1.0成比例明显下降。然而,肺循环障碍也会影响COPD的预后。重度COPD患者常出现肺动脉高压。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验